SPRO SPERO THERAPEUTICS INC

Ownership history in Shay Capital LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Shay Capital LLC reported a position in SPERO THERAPEUTICS INC (SPRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2024 Q1)
Avg. % of fund
0.02%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 60,289 -3,378 -5.3% 0.01% $140K $2.33
2025 Q3 ADDED 63,667 +38,667 +154.7% 0.01% $120K $1.88
2024 Q3 UNCHANGED 25,000 0% 0.00% $34K $1.34
2024 Q2 REDUCED 25,000 -281,967 -91.9% 0.00% $32K $1.30
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPRO price (monthly, adj. close)
← Back to Shay Capital LLC Holdings